Clasado Biosciences  (‘Clasado’), a global leader in the development of clinically proven prebiotic ingredient and product solutions for the human gut microbiome, has announced the appointment of Henning Søgaard as its new Chairman of the Board.  

With more than 30 years’ experience in the food, pharmaceutical, biotech and personal care sectors, Henning is a natural fit for Clasado as the business continues to grow and extend its global reach. Highly experienced in top-level management and business acquisitions, Henning has held high-profile roles in recent years with NutraQ, Impilo and Apoteka.  

Per Rehné, CEO at Clasado Biosciences, commented: “We are delighted to welcome Henning to the board, in what is a very exciting time for the business. He has extensive experience in driving commercial growth and his emphasis on meaningful, targeted development over ‘growth for growth’s sake’ is absolutely in line with our core strategy. We look forward to Henning’s contribution to the business as we execute our vision for the future of microbiome science.  

“I would also like to take the opportunity to give our sincere thanks to Henning’s predecessor, Moncef Slaoui. Moncef has made immeasurable contributions in his time as Chairman and we wish him all the best as he focuses his efforts on heading Operation Warp Speed – the US Government’s Covid-19 vaccination development programme.” 

Henning Søgaard commented: “Clasado is clearly a forward-thinking business and a leader in the growing gut health marketplace. That doesn’t happen by accident; it takes an experienced and talented team to create a strategic foothold and build on this. Despite its growth, I believe we can accelerate the business even further.  

“Around the world, consumers are engaging with the prebiotic category on a level unseen before. The team at Clasado is primed and perfectly placed to help food and nutraceutical brands deliver what today’s consumers are demanding. The key components for success are there; an ingredient backed by more than 90 clinical studies and the versatility to deliver flexibility and value for savvy brands. I’m excited by the opportunity presented and look forward to starting work with the Board and team.” 

For more information regarding Clasado Biosciences, please visit www.clasado.com